Verve Therapeutics Inc (VERV)
6.35
+0.31
(+5.13%)
USD |
NASDAQ |
Nov 05, 16:00
6.35
0.00 (0.00%)
After-Hours: 16:07
Verve Therapeutics Market Cap: 537.37M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 511.13M |
| November 01, 2024 | 501.82M |
| October 31, 2024 | 484.90M |
| October 30, 2024 | 489.98M |
| October 29, 2024 | 506.90M |
| October 28, 2024 | 502.67M |
| October 25, 2024 | 505.21M |
| October 24, 2024 | 484.05M |
| October 23, 2024 | 468.82M |
| October 22, 2024 | 481.51M |
| October 21, 2024 | 469.67M |
| October 18, 2024 | 478.13M |
| October 17, 2024 | 462.05M |
| October 16, 2024 | 473.90M |
| October 15, 2024 | 473.05M |
| October 14, 2024 | 425.66M |
| October 11, 2024 | 395.20M |
| October 10, 2024 | 389.27M |
| October 09, 2024 | 386.73M |
| October 08, 2024 | 382.50M |
| October 07, 2024 | 405.35M |
| October 04, 2024 | 423.12M |
| October 03, 2024 | 399.43M |
| October 02, 2024 | 406.20M |
| October 01, 2024 | 405.35M |
| Date | Value |
|---|---|
| September 30, 2024 | 409.58M |
| September 27, 2024 | 421.43M |
| September 26, 2024 | 419.74M |
| September 25, 2024 | 403.66M |
| September 24, 2024 | 418.89M |
| September 23, 2024 | 424.82M |
| September 20, 2024 | 439.20M |
| September 19, 2024 | 455.28M |
| September 18, 2024 | 466.28M |
| September 17, 2024 | 456.13M |
| September 16, 2024 | 458.66M |
| September 13, 2024 | 465.43M |
| September 12, 2024 | 478.13M |
| September 11, 2024 | 496.75M |
| September 10, 2024 | 474.74M |
| September 09, 2024 | 475.59M |
| September 06, 2024 | 473.47M |
| September 05, 2024 | 467.97M |
| September 04, 2024 | 516.21M |
| September 03, 2024 | 514.52M |
| August 30, 2024 | 566.98M |
| August 29, 2024 | 518.75M |
| August 28, 2024 | 496.75M |
| August 27, 2024 | 467.13M |
| August 26, 2024 | 432.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
372.35M
Minimum
Aug 14 2024
3.551B
Maximum
Sep 10 2021
1.270B
Average
1.121B
Median
Jun 26 2023
Market Cap Benchmarks
| Ardelyx Inc | 1.354B |
| Biomarin Pharmaceutical Inc | 12.59B |
| Sage Therapeutics Inc | 363.06M |
| ALX Oncology Holdings Inc | 79.80M |
| Immuneering Corp | 58.71M |
Market Cap Related Metrics
| PS Ratio | 24.03 |
| Price to Book Value | 0.9840 |
| Price | 6.35 |
| Earnings Yield | -40.79% |